ARCHIVES

New Drug Reverses Damage To Liver In Stem Cell Transplant

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

HPV DNA Testing Reduced Cervical Cancer Precursors

September 24, 2010

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

NCI-Approved Trials Listed

April 28, 2006

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

Sharfstein To Leave FDA

January 7, 2011